1 / 19

Section 10: Nutrients and their functions

Section 10: Nutrients and their functions. Vitamin K and blood clot formation. 01/27/06. Vitamin K. The RDA for vitamin K is 80 m g for men and 65 m g for women (age 18-50). Fat soluble. Common to many foods, and produced by intestinal bacteria.

grace
Télécharger la présentation

Section 10: Nutrients and their functions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Section 10: Nutrients and their functions • Vitamin K and blood clot formation 01/27/06

  2. Vitamin K • The RDA for vitamin K is 80 mg for men and 65 mg for women (age 18-50). • Fat soluble. • Common to many foods, and produced by intestinal bacteria. • Required for the carboxylation of glutamate side chains of several proteins, especially those involved in blood coagulation. 1

  3. Hemostasis • There are three immediate responses to blood vessel trauma. • Vascular spasm • platelet aggregation (and release of vasoconstrictors: thromboxane A2, serotonin, epinephrine). • Fibrin clot formation (requires vitamin K) • The mesh of fibrin clots and aggregated platelets plug the opening. • Clot formation occurs as a result of a cascade of proteolytic reactions. 2

  4. Clot Formation • Soluble fibrinogen is circulating in the blood. • Thrombin is a proteolytic enzyme that hydrolyzes fibrinogen to fibrin monomer and small fibrinopeptides A and B. • Fibrin is insoluble and aggregates. • Thrombin also activates transglutaminase (factor XIIIa) which cross-links fibrin monomers, making the clot mechanically strong. 3

  5. Fibrin Aggregation • Fibrin monomers spontaneously aggregate into long rod-shaped structures. • The structure is mechanically weak. 4

  6. Crosslinking Reaction • Peptide bonds connect glutamine and lysine residues on different fibrin monomers in the fibrin aggregate. • Catalyzed by transglutaminase (XIIIa). • This greatly strengthens the aggregate. p287 5

  7. Fibrinogen • Fibrinogen is a 340 kD complex of 2 Aa, 2 Bb and 2 g subunits. • Thrombin removes A and B proteolytically from the amino ends of the Aa and Bb subunits, producing fibrin monomer and 4 small fragments (fibrinopeptides). Fig. 10.38 6

  8. Fibrin monomer to fibrin clot • Fibrin monomer is insoluble and polymerizes. • The globular carboxy ends of g bind the thrombin-modified amino ends (“knobs”) of red Aa subunits. • The globular carboxy ends of blue Bb bind the amino ends of neighboing Bb to form cable structures (not shown). Fig. 10.40 7

  9. Fig. 10.37 Clot Cascade • A series of enzyme activations by proteolytic cleavage lead to fibrin clot production. • Fibrin is active to aggregate. It is not a proteolytic enzyme. • Factor VIII is the anti-hemophilia factor. VIIIa is more active than VIII. 8

  10. INTRINSIC PATHWAY. A foreign surface (collagen) activates high-molecular-weight kininogen, prekallikrein. Kallikrein activates factor XII. XIIa produces more kallikrein, in an autoactivation cycle. EXTRINSIC PATHWAY. Trauma activates factor VII and releases tissue factor (III), a lipoprotein from blood vessels. Tremendous amplification. Each step is proteolytic conversion of proteolytic enzyme to its active form (subscript ‘a’). VIIIa, tissue factor, and fibrin are not enzymes. Intrinsic and Extrinsic Pathways 9

  11. Intrinsic and Extrinsic Pathways Converge to Produce Thrombin • Both pathways are required for adequate levels of Xa to produce sufficient amounts of thrombin. • PF3 is platelet factor 3. 10

  12. Prothrombin Structure Prothrombin Fig. 10.41 • Xa cleaves prothrombin at two sites to produce thrombin, a serine protease. • Gla and kringle domains keep prothrombin inactive. • Ten glu residues at the amino end of the Gla domain are carboxylated. • The g-carboxyglutamates bind Ca2+ and are required for prothrombin to have the correct conformation to be a substrate for Xa, and they anchor it to platelet membranes at trauma sites. Fig. 10.43 11

  13. Carboxylation of Glutamate • Glutamate sidechains are converted to g-carboxyglutamate in factors VII, IX, X and prothrombin. • The two carboxyls of g-carboxyglutamate chelate Ca2+. • This is an example of post-translational modification. 12

  14. Vitamin K Reaction Cycle • Vitamin K is a cofactor for glutamate carboxylation reaction. • The reductases use NADPH as an e- source. 13

  15. Thrombin Inactivation • Clot formation and degradation are under close control. • The protein antithrombin III binds to thrombin, is proteolyzed, and irreversibly inactivates the thrombin (not shown). • The polysaccharide heparin enhances the binding of antithrombin III to thrombin. 14

  16. Plasmin activation • Plasminogen is bound in the fibrin-platelet mesh. • TPA finger and growth domains bind fibrin and anchor TPA to a clot. • TPA converts plasminogen to plasmin, which proteolytically degrades the clot. • TPA is used therapeutically to reduce clot formation after a heart attack or stroke. Stryer 4th 15

  17. Fibronectin • Fibronectin is a large multidomain glycoprotein present in connective tissue. • At sites of trauma it helps to “coordinate” the repair process by binding several of the proteins involved. Fig. 11-33 Stryer 3rd 16

  18. Vitamin K Analogs • Menadiol is a water-soluble vitamin K analog. • Warfarin is a potent inhibitor of clot formation, used after heart attacks, and also as rat poison (at higher doses). 17

  19. Next topic: Reactive oxygen species

More Related